By visiting our website or using services provided by Sai Life Sciences, you are accepting the practices described in the Privacy Policy.

We also use cookies on our websites. Cookies allow us to give you the best browsing experience and help us to understand how you use our site. You can disable cookies but parts of our website may not work. By continuing to use this website, you agree that we may store and access cookies on your device.

By clicking “I Accept”, you confirm that you are above the age of 16, that you have read and understood the Cookies Usage and the Privacy Policy, and that you agree to the collection, use and processing of your Personal Information by Sai Life in accordance with said policies.

I accept

Stay up to date with our newsletter

Get in touch!

To explore career opportunities with Sai Life Sciences, share your CV here.

Lets start the conversation!

Sign up to our newsletter

Thank you!
We will be in touch shortly.

Investors

Sai Life Sciences is a full-service CRDMO empowering global pharmaceutical and biotech innovators across the development lifecycle. With strategic investments in high-potency capabilities, digital platforms, and sustainability, we are evolving to meet the demands of next-generation molecules. Our strong customer relationships, operational agility, and commitment to responsible growth position us to deliver consistent performance and long-term stakeholder value.

Investor Relations

Financial Performance Highlights

Sai Life Sciences' modern industrial facility at sunset, representing innovation, growth, and commitment to excellence for investors.
Sai Life Sciences' modern industrial facility at sunset, representing innovation, growth, and commitment to excellence for investors.

Corporate Governance

Dr K Ranga Raju

Dr. K. Ranga Raju

Chairman

Krishna Kanumuri

Managing Director and CEO

Siva Chittor

Siva Chittor

Whole-Time Director and Chief Financial Officer

Ramesh G Iyer

Ramesh G Iyer

Independent Director

Suchita Sharma

Suchita Sharma

Independent Director

Dr. Dinesh V Patel

Independent Director

Siva Chittor

Siva Chittor

Whole-Time Director and Chief Financial Officer

Runa Karan, Company Secretary and Legal Head at Sai Life Sciences

Runa Karan

Company Secretary, Compliance Officer and Legal Head

KEY ITEMS

Download

Committees of the board

KEY ITEMS

Download

CG Report for Quarter ending 30.06.2025

CG Report for Quarter ending 31.03.2025

CG Report for Quarter ending 31.12.2024

KEY ITEMS

Download

Basis of Allotment (BoA) AD

Prospectus

Red Herring Prospectus

Draft Red Herring Prospectus

Frost & Sullivan Industry Report

Corporate Policies/Documents

KEY ITEMS

Download

Anti-Sexual Harassment Policy

Archival Policy

Code of Conduct for BoD and SMPs

Code of Practices-Fair Disclosure of UPSI

Corporate Social Responsibility Policy

Determining Material Subsidiaries

Insider Trading Policy

Nomination and Remuneration Policy

Policy for Determination of Materiality

Policy for Evaluation of Performance of BoD

Policy for Familiarisation Programme for ID

Policy for Preservation of Documents

Policy on Related Party Transactions

Policy to Promote Diversity of Board of Directors

Risk Management Policy

Succession Policy

UPSI Leak Inquiry Policy

Whistle Blower Policy

Code of conduct for NEDs

Terms and Conditions for appointment of Independent Director

Disclosure of Contact details of KMP as per Reg 30(5)

Familiarisation Programme for Id

Material Contracts

KEY ITEMS

Download

Offer Agreement

Amendment to Offer Agreement

Registrar Agreement

Amendment to Registrar Agreement

Monitoring Agency Agreement

Cash Escrow and Sponsor Banks Agreement

Share Escrow Agreement

Syndicate Agreement

Material Documents

KEY ITEMS

Download

Certified Copies of MoA and AoA

Certificate of Incorporation

Certificate of Commencement for Business

BR Approving the Offer and Related Matters

SR Approving Fresh Issue and Other Related Matters

BR Approving DRHP

BR Approving RHP

BR taking on record the approval for OFS by each of selling shareholders

IPO committee resolution taking on record consent to participate in OFS by each of selling shareholders

Audit committee resolution approving KPIs for disclosure

BR and SR for approval of revised remuneration structure of MD and CEO

BR and SR for approval of revised remuneration structure of Chairman and WTD

Scheme of arrangement between Company, Sai Quest Syn and their respective shareholders and creditors along-with Valuation report

Gift Deed along-with supplementary letter

Consent letters and authorisations from selling shareholders

Deloitte Consent Letter

Vishvakarma Consultancy Services Consent Letter

Annual Reports of the Company for Fiscal year 2024

Annual Reports of the Company for Fiscal year 2023

Annual Reports of the Company for Fiscal year 2022

Examination Report

Loan utilization certificate

Statement of Possible Special Tax Benefits certificate

Consents by Directors, Company Secretary, Compliance Officer and Legal Head, legal counsels to the Company, Bankers to the Company, Banker(s) to the Offer, the BRLMs, Syndicate Members, Registrar to the offer to act in respective capacities

Certificate by Bashetty & Joshi certifying KPIs

Certificate by Bashetty & Joshi certifying Basis for Offer price

Certificate by Bashetty & Joshi certifying weighted average cost of acquisition

Certificate by Bashetty & Joshi certifying details of Employee Stock options scheme

Certificate by Bashetty & Joshi certifying details of outstanding borrowings

Certificate by Bashetty & Joshi certifying dues owed to material creditors, MSME enterprises and other creditors

Frost & Sullivan report

Frost & Sullivan consent

Shareholders’ agreement dated March 27, 2019 along-with amendment agreement dated July 4, 2024

Agreement dated November 27, 2023 along-with amendment agreement dated July 10, 2024

Due diligence certificate dated July 24, 2024

In-principle listing approvals by NSE and BSE

SEBI Final observation letter

Tripartite agreement between Company, NSDL and Registrar of the Offer

Tripartite agreement between Company, CDSL and Registrar of the Offer